Which GLP-1 program may fit you?

The chart above ranks telehealth companies that prescribe GLP-1 medication when a clinician decides it is appropriate. Programs differ more than their landing pages suggest, so match the program type to your situation:

• Brand-name access programs suit people who want Wegovy or Zepbound specifically and may have insurance coverage to check first.
• Flat-price programs suit people paying cash who want one number that covers the visit, medication, and shipping.
• Coaching-inclusive programs suit people who want nutrition guidance and habit support bundled with the prescription.
• Compounded-medication programs advertise lower prices, but ask which pharmacy fills the order and what oversight is included — compounded versions are not the same as FDA-approved brand products.

What do GLP-1 trials actually show?

In the STEP 1 trial, adults taking once-weekly semaglutide 2.4 mg with lifestyle intervention averaged a 14.9% reduction in body weight at week 68, versus 2.4% for the placebo group.

In SURMOUNT-1, tirzepatide with lifestyle intervention produced average reductions of 15.0%, 19.5%, and 20.9% at 72 weeks across the 5 mg, 10 mg, and 15 mg doses, versus 3.1% for placebo. Longer follow-up from the same trial program also observed weight regain after participants stopped treatment — a reason to plan for maintenance, not just a start date.

These are trial averages under medical supervision, not guarantees. Individual results depend on eligibility, dose, side-effect tolerance, adherence, and the lifestyle changes that accompany treatment.

How is GLP-1 treatment taken?

Both semaglutide and tirzepatide for weight management are once-weekly injections given under the skin. Doses start low and increase gradually — Zepbound, for example, is titrated over 4 to 20 weeks to reach its target dose, according to the FDA. Your prescriber sets the schedule; follow it rather than adjusting on your own.

The FDA lists nausea, diarrhea, vomiting, constipation, abdominal discomfort, injection-site reactions, and fatigue among common side effects for tirzepatide. A good program tells you in advance how to reach the care team if symptoms appear, and GLP-1 medications should not be combined with each other.

What happens after you sign up?

Every legitimate telehealth GLP-1 program follows the same basic path: you complete a health intake, a licensed clinician reviews it, and the prescription is either issued or declined. If approved, medication ships to your home or goes to a pharmacy, and the program should explain dosing, storage, refills, and side-effect handling before your first injection.

The differences that matter show up after checkout: how fast refills arrive, whether you can message a clinician, and what happens to your subscription if you pause treatment. Those are the questions worth asking before you pick a program — not just the advertised first-month price.

Who may not be a good fit?

GLP-1 treatment is not appropriate during pregnancy or while planning pregnancy. The FDA also warns against tirzepatide for people with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2, and notes it has not been studied in people with a history of pancreatitis or severe gastrointestinal disease.

If you are not comfortable with weekly injections, prefer in-person care, or need the lowest possible cost, an oral medication program or a coaching-based plan may serve you better. A licensed health care professional can help you weigh the options against your medical history.